Renaissance Technologies’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-321,128
Closed -$739K 3614
2023
Q2
$739K Buy
321,128
+46,137
+17% +$106K ﹤0.01% 2664
2023
Q1
$833K Buy
274,991
+239,855
+683% +$727K ﹤0.01% 2593
2022
Q4
$82K Sell
35,136
-10,524
-23% -$24.6K ﹤0.01% 3682
2022
Q3
$87K Buy
+45,660
New +$87K ﹤0.01% 3637
2021
Q2
Sell
-1,004,500
Closed -$3.35M 3412
2021
Q1
$3.35M Buy
1,004,500
+566,537
+129% +$1.89M ﹤0.01% 1901
2020
Q4
$1.56M Buy
+437,963
New +$1.56M ﹤0.01% 2276
2020
Q3
Sell
-61,207
Closed -$111K 3337
2020
Q2
$111K Buy
+61,207
New +$111K ﹤0.01% 3256
2019
Q4
Sell
-168,312
Closed -$257K 3472
2019
Q3
$257K Sell
168,312
-9,888
-6% -$15.1K ﹤0.01% 3076
2019
Q2
$371K Buy
+178,200
New +$371K ﹤0.01% 3098
2018
Q4
Sell
-48,766
Closed -$461K 3346
2018
Q3
$461K Sell
48,766
-201,886
-81% -$1.91M ﹤0.01% 2873
2018
Q2
$1.83M Buy
250,652
+7,152
+3% +$52.2K ﹤0.01% 2308
2018
Q1
$1.22M Sell
243,500
-159,073
-40% -$796K ﹤0.01% 2574
2017
Q4
$2.03M Buy
402,573
+241,963
+151% +$1.22M ﹤0.01% 2338
2017
Q3
$996K Sell
160,610
-49,629
-24% -$308K ﹤0.01% 2573
2017
Q2
$757K Buy
210,239
+85,666
+69% +$308K ﹤0.01% 2654
2017
Q1
$405K Buy
124,573
+110,499
+785% +$359K ﹤0.01% 2830
2016
Q4
$34K Sell
14,074
-102,026
-88% -$246K ﹤0.01% 3188
2016
Q3
$399K Buy
116,100
+37,885
+48% +$130K ﹤0.01% 2876
2016
Q2
$272K Sell
78,215
-198,585
-72% -$691K ﹤0.01% 2971
2016
Q1
$1.14M Sell
276,800
-79,200
-22% -$327K ﹤0.01% 2518
2015
Q4
$1.58M Buy
356,000
+245,900
+223% +$1.09M ﹤0.01% 2249
2015
Q3
$671K Buy
+110,100
New +$671K ﹤0.01% 2536
2015
Q1
Sell
-26,700
Closed -$408K 3136
2014
Q4
$408K Buy
26,700
+3,800
+17% +$58.1K ﹤0.01% 2491
2014
Q3
$485K Sell
22,900
-127,300
-85% -$2.7M ﹤0.01% 2317
2014
Q2
$1.96M Buy
150,200
+125,200
+501% +$1.64M ﹤0.01% 1740
2014
Q1
$543K Buy
+25,000
New +$543K ﹤0.01% 2327